As the opioid crisis continues to take lives in big cities and small communities across Canada, a Kingston technology company has developed a rapid testing system to identify the lethal contaminants sometimes present in street drugs.
Spectra Plasmonics’ drug analysis system identifies the unique chemical “fingerprints” of various substances found in a sample and can detect the presence of dangerous contaminants such as fentanyl.
The technology is currently being piloted at a supervised consumption site in Kingston, but company officials say they’re eager to roll out the devices across North America.
(Sponsored)
Family-owned Coke Canada Bottling investing to grow in Ottawa-Gatineau
Have you ever wondered where your favourite Coca-Cola products come from? Few people in know that over 300 popular beverages products, like Coca-Cola, Coke Zero, Fuze, Fanta, Monster Energy, A&W
Invest with confidence: Hydro Ottawa funds technical studies for business retrofits
For Ottawa businesses, the opportunity to improve building performance has never been greater. Energy retrofits can cut emissions, strengthen operations, extend the life of assets, reduce operating costs, and position
“We want this to be in the hands of everybody whose job it is to save lives in this crisis,” says company co-founder and CEO Malcolm Eade.
Learn more about Spectra Plasmonics by watching the full interview with Eade above.
